KLRG1 impairs CD4+ T cell responses via p16ink4a and p27kip1 pathways: Role in hepatitis B vaccine failure in individuals with hepatitis C virus infection

Journal of Immunology

Volumn 192, Issue 2, 2014, Pages 649-657

  Shi, Lei ^a,b   Wang, Jia M ^a,c   Ren, Jun P ^a   Cheng, Yong Q ^a,d   Ying, Ruo S ^a,e   Wu, Xiao Y ^a   Lin, Shu M ^b   Griffin, Jeddidiah W D ^a   Li, Guang Y ^a   Moorman, Jonathan P ^a,f   Yao, Zhi Q ^a,f  

^a East Tennessee State University   (United States)

^b XI'AN JIAOTONG UNIVERSITY   (China)

^c MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^d BEIJING 302 HOSPITAL   (China)

^e Guangzhou Eighth People's Hospital   (China)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN E; HEPATITIS A HEPATITIS B VACCINE; HEPATITIS B VACCINE; INTERLEUKIN 2; NATURAL KILLER CELL LECTIN LIKE RECEPTOR; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY G MEMBER 1; PROTEIN KINASE B; RECOMBINANT HEPATITIS B VACCINE; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CD4+ T LYMPHOCYTE; CELL AGING; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; HEPATITIS C; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SENESCENCE; SIGNAL TRANSDUCTION; VACCINE FAILURE;

AGING; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; COINFECTION; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P27; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HEPATITIS C; HUMANS; INTERLEUKIN-2; LECTINS, C-TYPE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS;

EID: 84892758835     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302069     Document Type: Article

References (49)

1. Yao, Z. Q., and J. P. Moorman. 2013. Immune exhaustion and immune senescence: two distinct pathways for HBV vaccine failure during HCV and/or HIV infection. [Review] Arch. Immunol. Ther. Exp. (Warsz.) 61: 193-201.
2. Wang, J. M., C. J. Ma, G. Y. Li, X. Y. Wu, P. Thayer, P. Greer, A. M. Smith, K. P. High, J. P. Moorman, and Z. Q. Yao. 2013. Tim-3 alters the balance of IL-12/IL-23 and drives TH17 cells: role in hepatitis B vaccine failure during hepatitis C infection. Vaccine 31: 2238-2245.
3. Moorman, J. P., J. M. Wang, Y. Zhang, X. J. Ji, C. J. Ma, X. Y. Wu, Z. S. Jia, K. S. Wang, and Z. Q. Yao. 2012. Tim-3 pathway controls regulatory and effector T cell balance during hepatitis C virus infection. J. Immunol. 189: 755-766.
4. Zarski, J. P., B. Bohn, A. Bastie, J. M. Pawlotsky, M. Baud, F. Bost-Bezeaux, J. Tran van Nhieu, J. M. Seigneurin, C. Buffet, and D. Dhumeaux. 1998. Characteristics of patients with dual infection by hepatitis B and C viruses. J. Hepatol. 28: 27-33. (Pubitemid 28122496)
5. Duberg, A. S., A. Törner, L. Davidsdóttir, S. Aleman, A. Blaxhult, A. Svensson, R. Hultcrantz, E. Bäck, and K. Ekdahl. 2008. Cause of death in individuals with chronic HBV and/or HCV infection, a nationwide community-based register study. J. Viral Hepat. 15: 538-550. (Pubitemid 351798992)
6. Moorman, J. P., C. L. Zhang, L. Ni, C. J. Ma, Y. Zhang, X. Y. Wu, P. Thayer, T. M. Islam, T. Borthwick, and Z. Q. Yao. 2011. Impaired hepatitis B vaccine responses during chronic hepatitis C infection: involvement of the PD-1 pathway in regulating CD4(+) T cell responses. Vaccine 29: 3169-3176.
7. Kramer, E. S., C. Hofmann, P. G. Smith, M. L. Shiffman, and R. K. Sterling. 2009. Response to hepatitis A and B vaccine alone or in combination in patients with chronic hepatitis C virus and advanced fibrosis. Dig. Dis. Sci. 54: 2016-2025.
8. Fisman, D. N., D. Agrawal, and K. Leder. 2002. The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis. Clin. Infect. Dis. 35: 1368-1375. (Pubitemid 35448965)
9. Godkin, A., M. Davenport, and A. V. Hill. 2005. Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness. Hepatology 41: 1383-1390. (Pubitemid 40774886)
10. De Silvestri, A., A. Pasi, M. Martinetti, C. Belloni, C. Tinelli, G. Rondini, L. Salvaneschi, and M. Cuccia. 2001. Family study of non-responsiveness to hepatitis B vaccine confirms the importance of HLA class III C4A locus. Genes Immun. 2: 367-372. (Pubitemid 33674251)
11. Salazar, M., H. Deulofeut, C. Granja, R. Deulofeut, D. E. Yunis, D. Marcus-Bagley, Z. Awdeh, C. A. Alper, and E. J. Yunis. 1995. Normal HBsAg presentation and T-cell defect in the immune response of nonresponders. Immunogenetics 41: 366-374.
12. Albarran, B., L. Goncalves, S. Salmen, L. Borges, H. Fields, A. Soyano, H. Montes, and L. Berrueta. 2005. Profiles of NK, NKT cell activation and cytokine production following vaccination against hepatitis B. APMIS 113: 526-535. (Pubitemid 41081477)
13. Goncalves, L., B. Albarran, S. Salmen, L. Borges, H. Fields, H. Montes, A. Soyano, Y. Diaz, and L. Berrueta. 2004. The nonresponse to hepatitis B vaccination is associated with impaired lymphocyte activation. Virology 326: 20-28. (Pubitemid 38943002)
14. Bauer, T., and W. Jilg. 2006. Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination. Vaccine 24: 572-577. (Pubitemid 43017822)
15. Bauer, T., M. Günther, U. Bienzle, R. Neuhaus, and W. Jilg. 2007. Vaccination against hepatitis B in liver transplant recipients: pilot analysis of cellular immune response shows evidence of HBsAg-specific regulatory T cells. Liver Transpl. 13: 434-442. (Pubitemid 46444473)
16. Höhler, T., B. Stradmann-Bellinghausen, R. Starke, R. Sänger, A. Victor, C. Rittner, and P. M. Schneider. 2002. C4A deficiency and nonresponse to hepatitis B vaccination. J. Hepatol. 37: 387-392. (Pubitemid 34969955)
17. Verkade, M. A., C. J. van Druningen, C. T. Op de Hoek, W. Weimar, and M. G. Betjes. 2007. Decreased antigen-specific T-cell proliferation by moDC among hepatitis B vaccine non-responders on haemodialysis. Clin. Exp. Med. 7: 65-71. (Pubitemid 47036745)
18. Desombere, I., T. Cao, Y. Gijbels, and G. Leroux-Roels. 2005. Nonresponsiveness to hepatitis B surface antigen vaccines is not caused by defective antigen presentation or a lack of B7 co-stimulation. Clin. Exp. Immunol. 140: 126-137. (Pubitemid 40461082)
19. Desombere, I., P. Hauser, R. Rossau, J. Paradijs, and G. Leroux-Roels. 1995. Nonresponders to hepatitis B vaccine can present envelope particles to T lymphocytes. J. Immunol. 154: 520-529.
20. Jacques, P., G. Moens, I. Desombere, J. Dewijngaert, G. Leroux-Roels, M. Wettendorff, and S. Thoelen. 2002. The immunogenicity and reactogenicity profile of a candidate hepatitis B vaccine in an adult vaccine non-responder population. Vaccine 20: 3644-3649. (Pubitemid 35223393)
21. Kim, M. J., A. N. Nafziger, C. D. Harro, H. L. Keyserling, K. M. Ramsey, G. L. Drusano, and J. S. Bertino, Jr. 2003. Revaccination of healthy nonresponders with hepatitis B vaccine and prediction of seroprotection response. Vaccine 21: 1174-1179. (Pubitemid 36139946)
22. Ramon, J. M., R. Bou, and J. Oromi. 1996. Low-dose intramuscular revaccination against hepatitis B. Vaccine 14: 1647-1650. (Pubitemid 27041917)
23. Rahman, F., A. Dahmen, S. Herzog-Hauff, W. O. Böcher, P. R. Galle, and H. F. Löhr. 2000. Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen. Hepatology 31: 521-527. (Pubitemid 30078622)
24. Nyström, J., K. Cardell, T. B. Björnsdottir, A. Fryden, C. Hultgren, and M. Sällberg. 2008. Improved cell mediated immune responses after successful re-vaccination of non-responders to the hepatitis B virus surface antigen (HBsAg) vaccine using the combined hepatitis A and B vaccine. Vaccine 26: 5967-5972.
25. Voehringer, D., M. Koschella, and H. Pircher. 2002. Lack of proliferative capacity of human effector and memory T cells expressing killer cell lectinlike receptor G1 (KLRG1). Blood 100: 3698-3702. (Pubitemid 35303941)
26. Ibegbu, C. C., Y. X. Xu, W. Harris, D. Maggio, J. D. Miller, and A. P. Kourtis. 2005. Expression of killer cell lectin-like receptor G1 on antigen-specific human CD8+ T lymphocytes during active, latent, and resolved infection and its relation with CD57. J. Immunol. 174: 6088-6094. (Pubitemid 40663797)
27. Robbins, S. H., S. C. Terrizzi, B. C. Sydora, T. Mikayama, and L. Brossay. 2003. Differential regulation of killer cell lectin-like receptor G1 expression on T cells. J. Immunol. 170: 5876-5885. (Pubitemid 36682566)
28. Ouyang, Q., W. M. Wagner, D. Voehringer, A. Wikby, T. Klatt, S. Walter, C. A. Müller, H. Pircher, and G. Pawelec. 2003. Age-associated accumulation of CMV-specific CD8+ T cells expressing the inhibitory killer cell lectin-like receptor G1 (KLRG1). Exp. Gerontol. 38: 911-920. (Pubitemid 36952673)
29. Voehringer, D., C. Blaser, P. Brawand, D. H. Raulet, T. Hanke, and H. Pircher. 2001. Viral infections induce abundant numbers of senescent CD8 T cells. J. Immunol. 167: 4838-4843. (Pubitemid 33009711)
30. McMahon, C. W., A. J. Zajac, A. M. Jamieson, L. Corral, G. E. Hammer, R. Ahmed, and D. H. Raulet. 2002. Viral and bacterial infections induce expression of multiple NK cell receptors in responding CD8(+) T cells. J. Immunol. 169: 1444-1452. (Pubitemid 34809189)
31. Wilson, D. C., S. Matthews, and G. S. Yap. 2008. IL-12 signaling drives CD8+ T cell IFN-gamma production and differentiation of KLRG1+ effector subpopulations during Toxoplasma gondii infection. J. Immunol. 180: 5935-5945.
32. Thimme, R., V. Appay, M. Koschella, E. Panther, E. Roth, A. D. Hislop, A. B. Rickinson, S. L. Rowland-Jones, H. E. Blum, and H. Pircher. 2005. Increased expression of the NK cell receptor KLRG1 by virus-specific CD8 T cells during persistent antigen stimulation. J. Virol. 79: 12112-12116. (Pubitemid 41279330)
33. Bengsch, B., H. C. Spangenberg, N. Kersting, C. Neumann-Haefelin, E. Panther, F. von Weizsäcker, H. E. Blum, H. Pircher, and R. Thimme. 2007. Analysis of CD127 and KLRG1 expression on hepatitis C virus-specific CD8+ T cells reveals the existence of different memory T-cell subsets in the peripheral blood and liver. J. Virol. 81: 945-953. (Pubitemid 46067919)
34. Bengsch, B., B. Seigel, M. Ruhl, J. Timm, M. Kuntz, H. E. Blum, H. Pircher, and R. Thimme. 2010. Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation. PLoS Pathog. 6: e1000947.
35. Henson, S. M., O. Franzese, R. Macaulay, V. Libri, R. I. Azevedo, S. Kiani-Alikhan, F. J. Plunkett, J. E. Masters, S. Jackson, S. J. Griffiths, et al. 2009. KLRG1 signaling induces defective Akt (ser473) phosphorylation and proliferative dysfunction of highly differentiated CD8+ T cells. Blood 113: 6619-6628.
36. Beld, M., M. Penning, M. McMorrow, J. Gorgels, A. V. D. Hoek, and J. Goudsmit. 1998. Different hepatitis C virus (HCV) RNA load profiles following seroconversion among injecting drug users without correlation with HCV genotype and serum alanine aminotransferase levels. J. Clin. Microbiol. 36: 872-877. (Pubitemid 28146261)
37. Patsoukis, N., J. Brown, V. Petkova, F. Liu, L. Li, and V. A. Boussiotis. 2012. Selective effects of PD-1 on Akt and Ras pathways regulate molecular components of the cell cycle and inhibit T cell proliferation. Sci. Signal. 5: ra46.
38. Martin, N., S. Raguz, G. Dharmalingam, and J. Gil. 2013. Co-regulation of senescence-associated genes by oncogenic homeobox proteins and polycomb repressive complexes. Cell Cycle 12: 2194-2199.
39. Chiocca, E. A. 2002. Oncolytic viruses. Nat. Rev. Cancer 2: 938-950. (Pubitemid 37328895)
40. Yao, Z. Q., A. Eisen-Vandervelde, S. N. Waggoner, E. M. Cale, and Y. S. Hahn. 2004. Direct binding of hepatitis C virus core to gC1qR on CD4+ and CD8+ T cells leads to impaired activation of Lck and Akt. J. Virol. 78: 6409-6419. (Pubitemid 38715939)
41. Yao, Z. Q., A. Eisen-Vandervelde, S. Ray, and Y. S. Hahn. 2003. HCV core/gC1qR interaction arrests T cell cycle progression through stabilization of the cell cycle inhibitor p27Kip1. Virology 314: 271-282. (Pubitemid 37153316)
42. Lindenstrøm, T., N. P. Knudsen, E. M. Agger, and P. Andersen. 2013. Control of chronic Mycobacterium tuberculosis infection by CD4 KLRG12 IL-2-secreting central memory cells. J. Immunol. 190: 6311-6319.
43. Wick, G., P. Jansen-Dürr, P. Berger, I. Blasko, and B. Grubeck-Loebenstein. 2000. Diseases of aging. Vaccine 18: 1567-1583. (Pubitemid 30109511)
44. Hayward, A. R., K. Buda, and M. J. Levin. 1994. Immune response to secondary immunization with live or inactivated VZV vaccine in elderly adults. Viral Immunol. 7: 31-36. (Pubitemid 24330461)
45. Stepanova, L., A. Naykhin, C. Kolmskog, G. Jonson, I. Barantceva, M. Bichurina, O. Kubar, and A. Linde. 2002. The humoral response to live and inactivated influenza vaccines administered alone and in combination to young adults and elderly. J. Clin. Virol. 24: 193-201. (Pubitemid 34154866)
46. Lefebvre, J. S., and L. Haynes. 2013. Vaccine strategies to enhance immune responses in the aged. Curr. Opin. Immunol. 25: 523-528.
47. Malaspina, A., S. Moir, S. M. Orsega, J. Vasquez, N. J. Miller, E. T. Donoghue, S. Kottilil, M. Gezmu, D. Follmann, G. M. Vodeiko, et al. 2005. Compromised B cell responses to influenza vaccination in HIV-infected individuals. J. Infect. Dis. 191: 1442-1450. (Pubitemid 40563355)
48. Rodriguez-Barradas, M. C., I. Alexandraki, T. Nazir, M. Foltzer, D. M. Musher, S. Brown, and J. Thornby. 2003. Response of human immunodeficiency virusinfected patients receiving highly active antiretroviral therapy to vaccination with 23-valent pneumococcal polysaccharide vaccine. Clin. Infect. Dis. 37: 438-447. (Pubitemid 36976504)
49. Ferrando-Martínez, S., E. Ruiz-Mateos, M. C. Romero- Sánchez, M. A. Muñoz-Fernández, P. P. Viciana, M. Genebat, and M. Leal. 2011. HIV infection-related premature immunosenescence: high rates of immune exhaustion after short time of infection. Curr. HIV Res. 9: 289-294.